ENTERAL PRECURSORS FOR UREA SYNTHESIS IN HUMANS

人体尿素合成的肠内前体

基本信息

  • 批准号:
    8166646
  • 负责人:
  • 金额:
    $ 0.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-12-01 至 2010-11-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall goal of our research is to achieve a deeper understanding of in vivo nitrogen metabolism in patients with urea cycle defects and of differences in the bioavailability of enteral vs. systemic sources of nitrogen. We, and others, have argued that stable isotopic investigations of nitrogen metabolism provide the most generally applicable approach to the assessment of the underlying metabolic state of urea cycle patients1, particularly those who have partial enzymatic deficiencies (e.g. heterozygous carriers of ornithine transcarbamylase deficiency (OTCD)). Our preliminary studies have led us to conclude that OTCD carriers and mildly affected hemizygous otcd males have a specific compromise in their ability to transfer the amide-N group of glutamine to urea. In these studies the OTCD carriers had near normal absolute rates of urea synthesis at protein intakes less than 0.8 g/kg/d AND sources of urea nitrogen other than glutamine appear to be of greater quantitative importance to these individuals than they are to normal subjects. In these studies, we propose to measure the relative flux of intestinally vs. systemically delivered 15N nitrogen precursors into [15N]urea. These measures in control subjects and in patients with partial reduction in urea cycle activity will determine whether differences in bioavailability of these different sources may underlie the tendency for such patients to become hyperammonemic during episodes of stress (where peripheral nitrogen mobilization predominates) vs. instances of increased protein intake (where enteral sources predominate). Ultimately, such studies may provide insight into the differences of enteral vs. parental sources of nutrition in critically ill states involving for example liver failure.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brendan Lee其他文献

Brendan Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brendan Lee', 18)}}的其他基金

Targeting TGFb In Osteogenesis Imperfecta
靶向 TGFb 治疗成骨不全症
  • 批准号:
    10736736
  • 财政年份:
    2023
  • 资助金额:
    $ 0.8万
  • 项目类别:
Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta
成骨不全中骨骼祖细胞的调节
  • 批准号:
    10528208
  • 财政年份:
    2022
  • 资助金额:
    $ 0.8万
  • 项目类别:
Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta
成骨不全中骨骼祖细胞的调节
  • 批准号:
    10665057
  • 财政年份:
    2022
  • 资助金额:
    $ 0.8万
  • 项目类别:
ALL OF US EVENINGS WITH GENETICS RESEARCH EDUCATION PROGRAM
我们所有的晚间遗传学研究教育计划
  • 批准号:
    10307410
  • 财政年份:
    2021
  • 资助金额:
    $ 0.8万
  • 项目类别:
ALL OF US EVENINGS WITH GENETICS RESEARCH EDUCATION PROGRAM
我们所有的晚间遗传学研究教育计划
  • 批准号:
    10663584
  • 财政年份:
    2021
  • 资助金额:
    $ 0.8万
  • 项目类别:
WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues
WNT1 在成骨不全和颅面骨骼组织干细胞中的功能
  • 批准号:
    10316864
  • 财政年份:
    2021
  • 资助金额:
    $ 0.8万
  • 项目类别:
ALL OF US EVENINGS WITH GENETICS RESEARCH EDUCATION PROGRAM
我们所有的晚间遗传学研究教育计划
  • 批准号:
    10804507
  • 财政年份:
    2021
  • 资助金额:
    $ 0.8万
  • 项目类别:
WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues
WNT1 在成骨不全和颅面骨骼组织干细胞中的功能
  • 批准号:
    10684863
  • 财政年份:
    2021
  • 资助金额:
    $ 0.8万
  • 项目类别:
Nitric Oxide and Bone Homeostasis in Patients with Argininosuccinate Lyase Deficiency
精氨基琥珀酸裂解酶缺乏症患者的一氧化氮和骨稳态
  • 批准号:
    9329788
  • 财政年份:
    2017
  • 资助金额:
    $ 0.8万
  • 项目类别:
Nitric Oxide and Bone Homeostasis in Patients with Argininosuccinate Lyase Deficiency
精氨基琥珀酸裂解酶缺乏症患者的一氧化氮和骨稳态
  • 批准号:
    9896758
  • 财政年份:
    2017
  • 资助金额:
    $ 0.8万
  • 项目类别:

相似海外基金

Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
  • 批准号:
    2140205
  • 财政年份:
    2022
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Standard Grant
Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
  • 批准号:
    2140196
  • 财政年份:
    2022
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Standard Grant
Atroposelective Synthesis of Hindered Amides - Exploration of Synthetic Peptide Catalysts -
受阻酰胺的天体选择性合成-合成肽催化剂的探索-
  • 批准号:
    504378162
  • 财政年份:
    2022
  • 资助金额:
    $ 0.8万
  • 项目类别:
    WBP Fellowship
Development of Peptide Chemical Modification Enabled by N-Halogenation of Amides
酰胺 N-卤化实现的肽化学修饰的发展
  • 批准号:
    22H02743
  • 财政年份:
    2022
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
  • 批准号:
    10532252
  • 财政年份:
    2021
  • 资助金额:
    $ 0.8万
  • 项目类别:
CAREER: SusChEM: Iron Catalysts for the Reduction of Amides
职业:SusChEM:用于还原酰胺的铁催化剂
  • 批准号:
    2146728
  • 财政年份:
    2021
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Continuing Grant
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
  • 批准号:
    10399712
  • 财政年份:
    2021
  • 资助金额:
    $ 0.8万
  • 项目类别:
Function of primary fatty acid amides as lipid mediators
伯脂肪酸酰胺作为脂质介质的功能
  • 批准号:
    20K21285
  • 财政年份:
    2020
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Nickel-Catalyzed Alpha-Arylation of Secondary Amides
镍催化仲酰胺的α-芳基化
  • 批准号:
    558383-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Canadian Graduate Scholarships Foreign Study Supplements
Catalytic Synthesis of Pharmaceutical Amides in Water
水中催化合成药用酰胺
  • 批准号:
    EP/T01430X/1
  • 财政年份:
    2020
  • 资助金额:
    $ 0.8万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了